{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:30:16Z","timestamp":1791340216872,"version":"4.3.1"},"reference-count":40,"publisher":"American Chemical Society (ACS)","issue":"10","license":[{"start":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T00:00:00Z","timestamp":1723507200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T00:00:00Z","timestamp":1723507200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T00:00:00Z","timestamp":1723507200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"name":"William and Mildred Peters Endowment fund"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol. Pharmaceutics"],"published-print":{"date-parts":[[2024,10,7]]},"DOI":"10.1021\/acs.molpharmaceut.4c00529","type":"journal-article","created":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T15:49:10Z","timestamp":1723564150000},"page":"5150-5158","source":"Crossref","is-referenced-by-count":1,"title":["Excipient-Induced Lattice Disorder in\u00a0Active Pharmaceutical Ingredient: Implications on Drug Product Continuous Manufacturing"],"prefix":"10.1021","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2154-9599","authenticated-orcid":true,"given":"Bhushan","family":"Munjal","sequence":"first","affiliation":[{"name":"Department of Pharmaceutics, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota 55455, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"DeBoyace","sequence":"additional","affiliation":[{"name":"Pfizer Worldwide Research and Development, Drug Product Design, Groton, Connecticut 06340, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengjuan","family":"Cao","sequence":"additional","affiliation":[{"name":"Pfizer World Research & Development, Drug Product Design, San Diego, California 92121, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph F.","family":"Krzyzaniak","sequence":"additional","affiliation":[{"name":"Pfizer Worldwide Research and Development, Drug Product Design, Groton, Connecticut 06340, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7251-7610","authenticated-orcid":true,"given":"Kapildev K.","family":"Arora","sequence":"additional","affiliation":[{"name":"Pfizer Worldwide Research and Development, Drug Product Design, Groton, Connecticut 06340, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6322-0575","authenticated-orcid":true,"given":"Raj","family":"Suryanarayanan","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota 55455, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2024,8,13]]},"reference":[{"key":"ref1\/cit1","doi-asserted-by":"publisher","DOI":"10.1002\/9781119600800.ch72"},{"key":"ref2\/cit2","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2019.07.016"},{"key":"ref3\/cit3","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13081311"},{"key":"ref4\/cit4","unstructured":"Pharmaceutical Engineering Continuous OSD Manufacturing - A Product\n& Patient Perspective; 2022 https:\/\/ispe.org\/pharmaceutical-engineering\/ispeak\/continuous-osd-manufacturing-product-patient-perspective."},{"key":"ref5\/cit5","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2021.01.035"},{"key":"ref6\/cit6","doi-asserted-by":"publisher","DOI":"10.3109\/03639048809151997"},{"key":"ref7\/cit7","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600640805"},{"key":"ref8\/cit8","doi-asserted-by":"publisher","DOI":"10.1021\/cg1013335"},{"key":"ref9\/cit9","doi-asserted-by":"publisher","DOI":"10.1021\/cg060838j"},{"key":"ref10\/cit10","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.3c00063"},{"key":"ref11\/cit11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.121065"},{"key":"ref12\/cit12","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-94174-5_6"},{"key":"ref13\/cit13","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.9b00386"},{"key":"ref14\/cit14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2012.07.003"},{"key":"ref15\/cit15","doi-asserted-by":"publisher","DOI":"10.1002\/jps.20448"},{"key":"ref16\/cit16","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2019.05.032"},{"key":"ref17\/cit17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2018.07.002"},{"key":"ref18\/cit18","doi-asserted-by":"publisher","DOI":"10.1016\/0001-6160(53)90006-6"},{"key":"ref19\/cit19","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfa.2008.06.040"},{"key":"ref20\/cit20","doi-asserted-by":"publisher","DOI":"10.1208\/pt040468"},{"key":"ref21\/cit21","doi-asserted-by":"publisher","DOI":"10.3109\/10837459809028643"},{"key":"ref22\/cit22","doi-asserted-by":"publisher","DOI":"10.1002\/jps.20185"},{"key":"ref23\/cit23","doi-asserted-by":"publisher","DOI":"10.1098\/RSPA.1938.0079"},{"key":"ref24\/cit24","doi-asserted-by":"publisher","DOI":"10.1088\/0959-5309\/56\/3\/303"},{"key":"ref25\/cit25","unstructured":"Bragg, W. H.; Bragg, W. L. The Crystalline State; G. Bells and Sons Ltd: 1949."},{"key":"ref26\/cit26","doi-asserted-by":"publisher","DOI":"10.1007\/BF02980596"},{"key":"ref27\/cit27","doi-asserted-by":"publisher","DOI":"10.1107\/S0021889878012844"},{"key":"ref28\/cit28","doi-asserted-by":"publisher","DOI":"10.1016\/j.rinp.2018.03.008"},{"key":"ref29\/cit29","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2016.04.020"},{"key":"ref30\/cit30","doi-asserted-by":"publisher","DOI":"10.1002\/jps.10508"},{"key":"ref31\/cit31","doi-asserted-by":"publisher","DOI":"10.1002\/jps.21138"},{"key":"ref32\/cit32","doi-asserted-by":"publisher","DOI":"10.1023\/A:1015970218980"},{"key":"ref33\/cit33","doi-asserted-by":"publisher","DOI":"10.1081\/PDT-100100540"},{"key":"ref34\/cit34","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2023.02.019"},{"key":"ref35\/cit35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2016.04.068"},{"key":"ref36\/cit36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2008.06.015"},{"key":"ref37\/cit37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpx.2021.100094"},{"key":"ref38\/cit38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.122054"},{"key":"ref39\/cit39","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5173(85)90140-1"},{"key":"ref40\/cit40","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-006-9058-6"}],"container-title":["Molecular Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.4c00529","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.4c00529","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T08:11:02Z","timestamp":1728288662000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/acs.molpharmaceut.4c00529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,13]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10,7]]}},"alternative-id":["10.1021\/acs.molpharmaceut.4c00529"],"URL":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.4c00529","relation":{},"ISSN":["1543-8384","1543-8392"],"issn-type":[{"value":"1543-8384","type":"print"},{"value":"1543-8392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,13]]}}}